(NASDAQ: CBLL) Ceribell's forecast annual revenue growth rate of 30.12% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Ceribell's revenue in 2025 is $65,444,000.On average, 2 Wall Street analysts forecast CBLL's revenue for 2025 to be $2,982,273,046, with the lowest CBLL revenue forecast at $2,976,713,454, and the highest CBLL revenue forecast at $2,987,832,639. On average, 2 Wall Street analysts forecast CBLL's revenue for 2026 to be $3,871,449,170, with the lowest CBLL revenue forecast at $3,809,217,602, and the highest CBLL revenue forecast at $3,933,680,738.
In 2027, CBLL is forecast to generate $5,120,564,076 in revenue, with the lowest revenue forecast at $5,120,564,076 and the highest revenue forecast at $5,120,564,076.